Pharmamel Drug Discovery
Current Promotions
No video available
Get in Touch
About
Pharmamel Spin-Off biotech R&D&I biotech spin-off from the University of Granada, which holds the technology license from the Andalusian Health Service and the University of Granada for an intravenous melatonin injectable to treat sepsis (the leading cause of hospital death in the world) After conducting two Phase II clinical trials and successfully demonstrating the safety and efficacy of the drug, the company has the perfect drug candidate
Keywords
investigacion y desarrollo, salud, melatonina, idi, enfermedades inflamatorias
Amenities
No amenities listed yet
Upcoming Events
No upcoming events scheduled
Frequently Asked Questions
No FAQs available for this business.
Reviews
No reviews yet. Be the first to review!
Social Links
No social media links available
Photo Gallery
No photos available
Contact Information
Business Info
Location
Business Hours
Business hours not available
Own This Business?
Unclaimed
Take control of your business page to update information, respond to reviews, and more.
Claim This Business